14 Follicular Lymphoma Clinical Trials in Boston, MA (2026)

Q: How do I join a clinical trial in Boston?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you.

Recruiting Follicular Lymphoma Studies in Boston

NCT06168019Recruiting

Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India

This study will be conducted as a prospective cohort study, enrolling all eligible women in their first trimester of pregnancy during a baseline visit during week 6-13 of pregnancy at Government Medic...

Boston, MA10,000 participantsBoston University

View Study Details

NCT06091254Recruiting

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma

This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin...

Boston, MA822 participantsRegeneron Pharmaceuticals

View Study Details

NCT07168499Recruiting

Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis

Inflammatory Bowel Disease (IBD), which includes Crohn's Disease (CD) and Ulcerative Colitis (UC), is a chronic, immune-mediated disease characterized by recurrent episodes of relapse. The goal of thi...

Boston, MA160 participantsMassachusetts General Hospital

View Study Details

NCT04844606Recruiting

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (CD). The study will last about 172 weeks ...

Boston, MA150 participantsEli Lilly and Company

View Study Details

NCT06691217Recruiting

Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis

The primary goal of this clinical trial is to test the hypothesis that the drug canakinumab (anti-IL-1B monoclonal antibody) decreases vascular inflammation when used by people with a history of coron...

Boston, MA120 participantsMassachusetts General Hospital

View Study Details

NCT06400004Recruiting

Lumason® Infusion vs. Bolus Administrations

A phase III study designed as a randomized, within-patient comparison of continuous infusion of diluted Lumason® versus the bolus administration of undiluted Lumason® for degree of LVO and assessment ...

Boston, MA106 participantsBracco Diagnostics, Inc

View Study Details

NCT05783609Recruiting

Epcoritamab and Rituximab for First-line Follicular Lymphoma

The purpose of this study is to determine how effective and safe the combination of rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and who have not received other trea...

Boston, MA100 participantsReid Merryman, MD

View Study Details

NCT04508088Recruiting

Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

The investigators will be evaluating bone marrow composition via magnetic resonance imaging in newly diagnosed adolescents with Crohn disease (CD) compared to healthy, matched controls. The investigat...

Boston, MA92 participantsMassachusetts General Hospital

View Study Details

NCT05332639Recruiting

Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility

The aim of this study is to develop and assess the feasibility and effect of a web-based, personalized risk-estimation for Crohn's disease (PRE-Crohn's) tool on behaviors and biomarkers associated wit...

Boston, MA80 participantsMassachusetts General Hospital

View Study Details

NCT07077395Recruiting

Finding Links Between Hot flASHes and CardioVascular Disease

The goal of this clinical trial is to learn if drug fezolinetant improves blood vessel health in women with moderate to severe hot flashes. The main questions it aims to answer are: Does drug fezolin...

Boston, MA80 participantsMassachusetts General Hospital

View Study Details

NCT06655415Recruiting

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

First-degree relatives of people with inflammatory bowel disease ("IBD," including Crohn's disease and ulcerative colitis) have an increased risk for developing IBD themselves. This study will follow ...

Boston, MA50 participantsMassachusetts General Hospital

View Study Details

NCT04331639Recruiting

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

The investigators will be administering oral high dose interval vitamin D, concurrently when participants are receiving biologic therapy for their inflammatory bowel disease. The investigators will be...

Boston, MA50 participantsBoston Children's Hospital

View Study Details

NCT06798012Recruiting

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

CIDP is an autoimmune disease. This means that the body's germ fighting (immune) system attacks itself. In CIDP, the immune system attacks the protective covering around the nerves called myelin. Over...

Boston, MA36 participantsTakeda

View Study Details

NCT07128641Recruiting

Odronextamab in Low Tumor Volume Advanced FL

The purpose of this study is to evaluate the safety and effectiveness of treating previously untreated Follicular Lymphoma (FL) with odronextamab. The name of the study drug in this research study is...

Boston, MA35 participantsGottfried von Keudell, MD PhD

View Study Details

About Follicular Lymphoma Clinical Trials in Boston

Follicular lymphoma is the second most common type of non-Hodgkin lymphoma and is typically a slow-growing (indolent) cancer. It develops from B-cells in the lymph nodes. Treatment ranges from watchful waiting to immunotherapy, chemotherapy, and targeted agents.

There are currently 14 follicular lymphoma clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 11,881 participants. Research is being sponsored by Boston University, Regeneron Pharmaceuticals, Massachusetts General Hospital and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Follicular Lymphoma Clinical Trials in Boston — FAQ

Are there follicular lymphoma clinical trials in Boston?

Yes, there are 14 follicular lymphoma clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.

Are clinical trials in Boston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.

What follicular lymphoma treatments are being tested?

The 14 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for follicular lymphoma.

Data updated July 13, 2026 from ClinicalTrials.gov